A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer
Eveline M. Dijkgraaf , Saskia J.A.M. Santegoets , An K.L. Reyners , Renske Goedemans
Oncotarget 6 ( 31) 32228 -32243
57
2015
Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands
Jos Luttjeboer , Didik Setiawan , Qi Cao , Toos CAHH Daemen
Vaccine 34 ( 50) 6381 -6387
1
2016
Virosomes for antigen and DNA delivery
T DAEMEN , A DEMARE , L BUNGENER , J DEJONGE
Advanced Drug Delivery Reviews 57 ( 3) 451 -463
80
2005
LIPOSOMES AS AN INVIVO TOOL TO STUDY AND MANIPULATE MACROPHAGE FUNCTION - DISCUSSION
G Gregoriadis , FC Szoka , CV Harding , L Huang
Research in Immunology 143 ( 2) 245 -256
1
1992
FRASER, KENETH B., 86
P BREKELMANS , T DAEMEN , JURATE T DAMBRAUSKAS , NOEL K DYSART JR
Clinical Immunology and Immunopathology 29 451 -452
1983
DIFFERENTIAL-EFFECTS OF LIPOSOME-INCORPORATION ON LIVER MACROPHAGE-ACTIVATING POTENCIES OF LPS, LIPID-A AND MDP - DIFFERENCES IN SUSCEPTIBILITY TO LYSOSOMAL-ENZYMES
G SCHERPHOF , J DIJKSTRA , T DAEMEN
Journal of Leukocyte Biology 44 ( 4) 295 -295
1988
Immunotherapy in ovarian cancer patients; involvement and manipulation of regulatory T cells.
CAHH Toos Daemen , CJM Kees Melief , HW Hans Nijman ,
2007
[Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses].
Tjalke A Westra , Toos Daemen , Jan C Wilschut , Maarten J Postma
Nederlands Tijdschrift voor Geneeskunde 153
2
2009
In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.
Aletta Veninga , Toos Daemen , Gerrit L. Scherphof , Frits H. Roerdink
Cancer Research 46 ( 9) 4330 -4335
77
1986
Expression of Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in Human Ovarian Tumors and Tumor-associated Macrophages
Claudia Kempinga , Harry Hollema , Alida H. Klimp , Elisabeth G. E. de Vries
Cancer Research 61 ( 19) 7305 -7309
172
2001
Differential effects of liposome-incorporation on liver macrophage activating potencies of rough lipopolysaccharide, lipid A, and muramyl dipeptide. Differences in susceptibility to lysosomal enzymes.
Jan Dijkstra , Gerrit Scherphof , Aletta Veninga , Toos Daemen
Journal of Immunology 142 ( 7) 2469 -2474
11
1989
LIVER METASTASIS MODEL OF COLON-CANCER IN THE RAT - IMMUNOHISTOCHEMICAL CHARACTERIZATION
Wim Timens , Toos Daemen , Pjk Kuppen , C Thomas
Invasion & Metastasis 13 ( 2) 102 -112
53
1993
Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization.
J Regts , Toos Daemen , Jan Wilschut , A Riezebos-Brilman
Antiviral Therapy 9 ( 5) 733 -742
55
2004
A virosomal immunization strategy against cervical cancer and pre-malignant cervical disease.
Jacqueline de Vries-Idema , Arjan de Mare , Laura Bungener , Toos Daemen
Antiviral Therapy 11 ( 6) 717 -727
18
2006
Chemo-immunotherapy of ovarian cancer in a murine tumour model.
Alida H. Klimp , Toos Daemen , Gerrit L. Scherphof , Elisabeth G. E. De Vries
Anticancer Research 20 ( 4) 2585 -2592
12
2000
Transfection of murine and human dendritic cells with recombinant Semliki Forest virus
Laura Bungener , Toos Daemen , Jan Wilschut , M Schoemaker
Journal of Leukocyte Biology
1998
Profylactische vaccins ter voorkoming van HPV-gerelateerde kanker
Toos Daemen , Jan Wilschut , Maarten Postma , Hans Nijman
Tijdschrift Kanker 32 6 -10
2008
Development of a therapeutic vaccine against chronic Hepatitis C virus infection
Toos Daemen , Jan Wilschut , P. P. Ip
Immunology 137 759 -759
2012
Functional heterogeneity between large and small Kupffer cells
Toos Daemen , Harry van Goor , Gerrit Scherphof , Machiel Hardonk
Cells of the hepatic sinusoid 2 434 -435
1
1989
Tumor cytotoxicity of macrophages induced by uptake of liposome-en¬capsula¬ted immuno¬modulators with special refe¬rence to Kupffer cells
A Veninga , Toos Daemen , GL Scherphof , FH Roerdink
Liposomes as drug carriers: trends and progress 431 -445
1988